Clinical Trial Update: KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy [Phase 2, Phase 3]

View source ↗

Summary

A trial update on KN026 in combination with chemotherapy for HER2-positive stomach (gastric) cancer patients after failure of first-line therapy, spanning Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• KN026

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Stomach Cancer | Phase 2, Phase 3 | Status: RECRUITING